The Doctor’s Advocate | Fourth Quarter 2019

Office of National Drug Control Strategy Promotes Building an Addiction Medicine Workforce

Roneet Lev, MD, Chief Medical Officer, Office of National Drug Control Policy

The Office of National Drug Control Policy (ONDCP), in partnership with the assistant secretary of health and the American College of Academic Addiction Medicine (ACAAM), hosted “Building the Addiction Medicine Workforce: Giving Americans Access to the Care They Need.” This White House event focused on building an addiction medicine physician workforce that can bring the necessary expertise to American families and communities.

When the event took place earlier this year, the director of ONDCP, Jim Carroll, the nation’s drug czar, opened the event with a brief overview of the Trump administration’s leadership on the issue of addiction medicine and the significant accomplishments seen in this field since the president took office. Director Carroll went on to elaborate that the top priority for ONDCP is “to save lives.” Admiral Brett Giroir, the assistant secretary of health, emphasized the federal government has an “all hands on deck” policy in dealing with the drug crisis across all federal agencies.

The nearly 100 professionals from across the country that participated in the addiction medicine event discussed addiction medicine with Dr. Nora Volkow, director of the National Institute on Drug Abuse (NIDA); Dr. George Koob, director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA); and Dr. George Sigounas, director of Health Resources and Services Administration (HRSA). All speakers and participants emphasized the realization that addiction is a chronic, relapsing disease of the brain that can indeed be prevented and treated.

The primary focus of the event was to address the workforce gap within the field of addiction medicine. Dr. Kevin Kunz, executive vice president of ACAAM, noted that of the 23.2 million Americans with a substance use disorder (SUD), only 10.7 percent receive treatment.1 There are 2,416 U.S. physicians who are credentialed and practicing as addiction psychiatrists, a subspecialty of psychiatry, yet there are only 1,928 primary care and other nonpsychiatrists certified in addiction medicine.2,3

Projections indicate a need for 7,500 addiction medicine physicians to meet the workforce needed to address SUD across healthcare. The physician workforce is built from one-year fellowship training programs after physicians complete a residency program. There are 50 accredited fellowships in addiction psychiatry, and these have been available since 1992. Addiction medicine was recognized as a unique field of practice by the American Board of Medical Specialties in 2016, and, in 2018, the Accreditation Council of Graduate Medical Education began accreditation of addiction medicine fellowships that are open to physicians of various specialties. There are currently 52 addiction medicine fellowships with a goal of establishing over 125 needed to build and maintain an adequate workforce of 7,500 addiction medicine physicians. In comparison, there are about 660,000 Americans who have kidney disease, and they are supported by 8,000 nephrologists.4,5 The nephrologists train new physician specialists through 148 fellowships nationwide.

The addiction medicine professionals also explored the financial impact of providing treatment to individuals suffering from SUD. Tami Mark and Gary Zarkin, from the nonprofit research institute RTI International, documented the compelling case that addiction medicine interventions not only save lives, but they are also cost-effective to insurers and health systems. America spends $521 billion annually on SUDs, and for each $1 spent on addiction treatment, we could save $7. Furthermore, for each $1 spent on prevention, we could save $18.6,7,8

Addiction medicine services play an important role throughout the medical continuum. The group heard about the importance of an inpatient addiction medicine service from Dr. Alex Walley, Boston University School of Medicine; primary care clinic services from Dr. Diana Coffa, University of California San Francisco; psychiatric services from Dr. Devang Ghandi, University of Maryland; the emergency department from Dr. Jeanette Tetrault, Yale; obstetrics and gynecology services by Dr. Patricia Wright from Hawaii; and pediatric care from Dr. Sharon Levy, Boston Children’s Hospital.

It is critical that health systems create addiction medicine services within their institutions. Five health systems shared their successes and visions, including reports by Lynn Eschenbaucher from Ascension Health, Peter Hill from Johns Hopkins, Jeffrey Cully from the Veterans Administration, Bruce Deighton from HCA, and Bryan Mills from Community Health Network in Indiana.

“Building the Addiction Medicine Workforce: Giving Americans Access to the Care They Need” supported ONDCP’s life-saving mission by encouraging the promotion of a more robust addiction medicine workforce. As ONDCP’s chief medical officer, I argue that in America, anyone who walks into a healthcare facility with SUD should be connected with an addiction specialist for treatment, just as a patient with a broken bone is given a referral to an orthopedic surgeon. The White House event demonstrated how the administration’s commitment to the people and families who struggle with addiction, coupled with the dedicated work of addiction medical professionals, presents a vision within reach.

For information on how your institution can start an addiction medicine fellowship, contact ACAAM.

Our thanks to Roneet Lev, MD, an emergency medicine physician who serves as chief medical officer in the Office of National Drug Control Policy. Prior to her role in the executive office of the president, she served as chief of the Emergency Department at Scripps Mercy Hospital in San Diego, California, where she is known for uniting the medical community to change the culture of overprescribing.


References

  1. National Survey on Drug Use and Health, 2017.
  2. Physician board certification data. American Board of Medical Specialties. https://www.boardcertifieddocs.com/abms/static/home.htm.
  3. Physician lookup. American Board of Preventive Medicine website. https://certification.theabpm.org/physician-lookup.
  4. Kidney disease statistics for the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases website. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease.
  5. Counts of nephrologists in the U.S. by year. Centers for Disease Control and Prevention. https://nccd.cdc.gov/CKD/detail.aspx?Qnum=Q238.
  6. Trends and statistics. National Institute on Drug Abuse website. www.drugabuse.gov/related-topics/trends-statistics.
  7. Miller T, Hendrie D. Substance abuse prevention dollars and cents: a cost-benefit analysis. DHHS Pub. No. (SMA) 07-4298. Rockville, MD: Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration, 2008.
  8. Ettner SL, Huang D, Evans E, et al. Benefit-cost in the California treatment outcome project: does substance abuse treatment “pay for itself”? Health Serv Res. 2006 Feb;41(1):192-213. Erratum in: Health Serv Res. 2006 Apr;41(2):613. PubMed PMID: 16430607; PubMed Central PMCID: PMC1681530.

The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.

Follow The Doctors Company on Twitter Watch The Doctors Company on YouTube The Doctors Company on LinkedIn Like The Doctors Company on Facebook

© ­ The Doctors Company. All rights reserved. Legal Notices and Privacy Policy | Do Not Sell My Info